Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Madhur Garg is a leading head and neck surgical oncologist whose research has fundamentally reshaped the management of oropharyngeal squamous cell carcinoma (OPSCCA) through the application of transoral robotic surgery (TORS). His work centers on optimizing treatment de-escalation, demonstrating how TORS can reduce the need for aggressive chemotherapy and radiotherapy while maintaining excellent oncologic outcomes. In his landmark 2015 study (66 citations), Dr. Garg prospectively assessed adjuvant therapy needs following TORS and neck dissection, providing critical evidence for surgical-first approaches. His 2018 work (50 citations) further quantified TORS’s impact on survival and chemotherapy utilization, showing that robotic surgery can spare patients from toxic multimodality treatments. Notably, Dr. Garg also identified a key risk in de-escalation: his 2013 study (9 citations) highlighted that omitting adjuvant radiotherapy after TORS may increase retropharyngeal node recurrence, establishing crucial safety parameters for treatment protocols. By balancing oncologic efficacy with functional preservation, Dr. Garg’s research has directly influenced clinical guidelines and improved quality of life for thousands of head and neck cancer patients worldwide.